Survey on the Use of Patient Materials for Pharmaceutical Development Programs
The ISCT European Legal and Regulatory Affairs Committee (EU LRA) invites you to participate in a survey on the Use of Patient Materials for Pharmaceutical Development Programs.
The objective of this questionnaire is to get an understanding of the technical and ethical challenges developers of autologous cell and tissue based products (ATMPs) are facing when using patient materials for (part of) their pharmaceutical development program.
The information collected through this questionnaire will be used by the ISCT EU LRA Committee to write a position paper so that the operators in the field, including ATMP product developers, Ethics Committees, and watchdogs get an understanding of the current challenges.
The paper will not refer to specific products and/or organizations/companies.
Please complete the survey by April 29, 2016. We thank you in advance for your participation.
ISCT EU LRA Committee